Maxzide

See also: Generic Maxzide-25

Maxzide is a brand name of hydrochlorothiazide/triamterene, approved by the FDA in the following formulation(s):

MAXZIDE (hydrochlorothiazide; triamterene - tablet; oral)

• 
  Manufacturer: MYLAN BERTEK
  
  Approval date: October 22, 1984
  
  Strength(s): 50MG;75MG ^[RLD][AB]

Has a generic version of Maxzide been approved?

Yes. The following products are equivalent to Maxzide:

TRIAMTERENE AND HYDROCHLOROTHIAZIDE (hydrochlorothiazide; triamterene tablet; oral)

• 
  Manufacturer: APOTEX INC
  
  Approval date: April 17, 1988
  
  Strength(s): 50MG;75MG ^[AB]


• 
  Manufacturer: PLIVA
  
  Approval date: January 31, 1996
  
  Strength(s): 50MG;75MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: June 17, 1988
  
  Strength(s): 50MG;75MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: April 17, 1988
  
  Strength(s): 50MG;75MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: November 30, 1988
  
  Strength(s): 50MG;75MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Maxzide. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Maxzide.

See also...

• Maxzide Consumer Information (Wolters Kluwer)
• Maxzide Consumer Information (Cerner Multum)
• Maxzide Advanced Consumer Information (Micromedex)
• Triamterene/Hydrochlorothiazide Consumer Information (Wolters Kluwer)
• Hydrochlorothiazide and triamterene Consumer Information (Cerner Multum)
• Triamterene and hydrochlorothiazide Advanced Consumer Information (Micromedex)